FDA Adverse Event Injury Summary report: N

CARPENTIER-EDWARDS PERIMOUNT MAGNA AORTIC BIOPROSTHESIS

MDR report key: 1246390 · Received November 21, 2008

Report

Report Number
6000002-2008-09337
Event Type
Injury
Date Received
November 21, 2008
Date of Event
October 28, 2008
Report Date
October 28, 2008
Manufacturer
EDWARDS LIFESCIENCES
Product Code
LWR
PMA / PMN Number
P860057S022
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

EVALUATION RESULTS: VALVE WAS RECEIVED WITH SERRATED MARKS ON ALL LEAFLETS. ON LEAFLET ONE: 5 MM FROM COMMISSURE ONE, 2 MM AND 6 MM FROM COMMISSURE TWO. ON LEAFLET TWO: 2 MM FROM COMMISSURE TWO, 1 MM, 2 MM AND 4 MM FROM COMMISSURE THREE. ON LEAFLET THREE: 1 MM, 2 MM AND 3 MM FROM COMMISSURE THREE. SURFACE DAMAGE/CUTS WERE ALSO OBSERVED ON TWO OF THE LEAFLETS. CUTS/SURFACE DAMAGES WERE NOTED ON LEAFLET TWO AND THREE, EACH 1 MM IN LENGTH. THE SEWING RING WAS CUT NEAR COMMISSURE TWO. NO VISIBLE INCONSISTENCIES WERE NOTED IN THE X-RAY. VALVE WAS SENT TO R&D FOR FUNCTIONAL TESTING. RESULTS: NO VISIBLE INCONSISTENCIES OBSERVED. THE DEVICE IS BEING SENT TO EDWARDS' R & D DEPARTMENT FOR FURTHER EVALUATION. ECHO REVIEW RESULTS: PROVIDED BY EDWARD'S INDEPENDENT CONSULTANT: IMPRESSION - AFTER THE FIRST PUMP RUN, THERE IS A BIOPROSTHESIS IN THE AORTIC POSITION WITH ASSOCIATED AORTIC REGURGITATION. AORTIC REGURGITATION APPEARS TO BE OF PARAPROSTHETIC ORIGIN, ORIGINATING NEAR THE COMMISSURAL POST BETWEEN THE RIGHT AND LEFT CORONARY CUSPS; AND IS PROBABLY MODERATE IN SEVERITY. THE BIOPROSTHESIS APPEARS OTHERWISE NORMAL AS VISUALIZED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE DEVICE WAS EXPLANTED AFTER IMPLANT DUE TO AORTIC INSUFFICIENCY OBSERVED ON THE POST OP TEE. THE PHYSICIAN SURGEON PROVIDED A COPY OF THE PATIENT'S POST OP TEE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CARPENTIER-EDWARDS PERIMOUNT MAGNA AORTIC BIOPROSTHESIS REPLACEMENT HEART VALVE LWR EDWARDS LIFESCIENCES 3000TFX R-08H1802

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention